View current press releases, to submit a press release please contact [email protected] for pricing.
LONDON, Nov. 30, 2023 /PRNewswire/ — Amwins Global Risks, the international arm of global specialty insurance broker Amwins and one of the largest independent wholesale brokers in London, announced today the appointment of Tom Graham as director of their casualty division.…
ST. PETERSBURG, Fla., Nov. 29, 2023 (GLOBE NEWSWIRE) — BayFirst Financial Corp. (f/k/a First Home Bancorp, Inc.) (OTCQX: FHBI) (“BayFirst” or the “Company”), parent company of First Home Bank, today announced that its common stock will begin trading tomorrow, November…
“2023 has been a year of continued growth and new opportunities for Victory Square. Q3 2023 was another strong quarter in which we achieved a seventh consecutive quarter with positive comprehensive income, issued a share dividend, and successfully listed Fantasy…
BOSTON, Nov. 30, 2023 /PRNewswire/ — As many as 40% of employees working in digital fields are actively job hunting, and nearly 75% are expecting to leave their current role in the near future. These were among the findings of a…
San Antonio, TX, Nov. 29, 2023 (GLOBE NEWSWIRE) — U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and specialized sectors, will continue its payment of monthly dividends in November.…
VANCOUVER, British Columbia, Nov. 29, 2023 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY and FSE: D7Q1) “Monument” or the “Company” today announced its first quarter of fiscal 2023 production and financial results for the three months ended September 30,…
NEW YORK, Nov. 29, 2023 /PRNewswire/ — Juan Monteverde, founder and managing partner of the firm Monteverde & Associates PC (“M&A Firm”), a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire…
PITTSBURGH, Nov. 29, 2023 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (NASDAQ: KRYS) (the “Company”), the leader in redosable gene therapies for rare diseases, today announced that it has commenced a $200 million underwritten public offering of its common stock. The…
PITTSBURGH, Nov. 29, 2023 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (NASDAQ: KRYS) (the “Company”), the leader in redosable gene therapies for rare diseases, today announced that it has commenced a $200 million underwritten public offering of its common stock. The…
TORONTO, Nov. 29, 2023 (GLOBE NEWSWIRE) — Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light activated compounds and their associated drug formulations with a…
